Marcella E. O'REilly

Marcella E. O'REilly

Auto-generated profile, based on publicly available information

Marcella E. O'REilly

Nutrigenomics Research Group, School of Public Health Physiotherapy and Sports Science, University College Dublin, Dublin 4, Ireland

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2017 in Biochemical Society Transactions
Verified
Journal Article
Closed access
AKAnna M. Kirwan
Anna M. Kirwan
YLYvonne M. Lenighan
Yvonne M. Lenighan
MOMarcella E. O'REilly
Marcella E. O'REilly
FMFiona C. McGillicuddy
Fiona C. McGillicuddy
HRHelen M Roche
Helen M Roche
Metabolic inflammation is a very topical area of research, wherein aberrations in metabolic and inflammatory pathways probably contribute to atherosclerosis, insulin resistance (IR) and type 2 diabetes. Metabolic insults arising from obesity promote inflammation, which in turn impedes insulin signalling and reverse cholesterol transport (RCT). Key cells in the process are metabolically activated macrophages, which up-regulate both pro- and anti-inflammatory pathways in response to lipid spillover from adipocytes. Peroxisome proliferator-activated receptors and AMP-activated protein kinase (AMPK) are regulators of cellular homeostasis that influence both inflammatory and metabolic pathways. Dietary fats, such as saturated fatty acids (SFAs), can differentially modulate metabolic inflammation. Palmitic acid, in particular, is a well-characterized nutrient that promotes metabolic inflammation via the NLRP3 (the nod-like receptor containing a pyrin domain) inflammasome, which is partly attributable to AMPK inhibition. Conversely, some unsaturated fatty acids are less potent agonists of metabolic inflammation. For example, monounsaturated fatty acid does not reduce AMPK as potently as SFA and n-3 polyunsaturated fatty acids actively resolve inflammation via resolvins and protectins. Nevertheless, the full extent to which nutritional state modulates metabolic inflammation requires greater clarification.

10 May 2016 in Circulation
Verified
Journal Article
Open access
PDF file
MOMarcella O’rEilly
Marcella O’rEilly
EDEugene Dillon
Eugene Dillon
WGWeili Guo
Weili Guo
OFOrla Finucane
Orla Finucane
AMAoibheann McMorrow
Aoibheann McMorrow
FMFiona McGillicuddy McGillicuddy
Fiona McGillicuddy McGillicuddy
Background—: Acute inflammation impairs reverse cholesterol transport (RCT) and reduces high-density lipoprotein (HDL) function in vivo. This study hypothesized that obesity-induced inflammation impedes RCT and alters HDL composition, and investigated if dietary replacement of saturated (SFA) for monounsaturated (MUFA) fatty acids modulates RCT. Methods and Results—: Macrophage-to-feces RCT, HDL efflux capacity, and HDL proteomic profiling was determined in C57BL/6j mice following 24 weeks on SFA- or MUFA-enriched high-fat diets (HFDs) or low-fat diet. The impact of dietary SFA consumption and insulin resistance on HDL efflux function was also assessed in humans. Both HFDs increased plasma 3 H-cholesterol counts during RCT in vivo and ATP-binding cassette, subfamily A, member 1–independent efflux to plasma ex vivo, effects that were attributable to elevated HDL cholesterol. By contrast, ATP-binding cassette, subfamily A, member 1–dependent efflux was reduced after both HFDs, an effect that was also observed with insulin resistance and high SFA consumption in humans. SFA-HFD impaired liver-to-feces RCT, increased hepatic inflammation, and reduced ABC subfamily G member 5/8 and ABC subfamily B member 11 transporter expression in comparison with low-fat diet, whereas liver-to-feces RCT was preserved after MUFA-HFD. HDL particles were enriched with acute-phase proteins (serum amyloid A, haptoglobin, and hemopexin) and depleted of paraoxonase-1 after SFA-HFD in comparison with MUFA-HFD. Conclusions—: Ex vivo efflux assays validated increased macrophage-to-plasma RCT in vivo after both HFDs but failed to capture differential modulation of hepatic cholesterol trafficking. By contrast, proteomics revealed the association of hepatic-derived inflammatory proteins on HDL after SFA-HFD in comparison with MUFA-HFD, which reflected differential hepatic cholesterol trafficking between groups. Acute-phase protein levels on HDL may serve as novel biomarkers of impaired liver-to-feces RCT in vivo.

9 January 2020 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
MOMarcella E. O'REilly
Marcella E. O'REilly
YLYvonne M. Lenighan
Yvonne M. Lenighan
EDEugene Dillon
Eugene Dillon
SKSarina Kajani
Sarina Kajani
SCSean Curley
Sean Curley
FMFiona McGillicuddy McGillicuddy
Fiona McGillicuddy McGillicuddy

9 November 2018 in Molecular Nutrition & Food Research
Verified
Journal Article
Open access
PDF file
MOMarcella E. O'REilly
Marcella E. O'REilly
SKSarina Kajani
Sarina Kajani
JRJessica C. Ralston
Jessica C. Ralston
YLYvonne M. Lenighan
Yvonne M. Lenighan
HRHelen M Roche
Helen M Roche
FMFiona McGillicuddy McGillicuddy
Fiona McGillicuddy McGillicuddy
Background: Cholesterol retention within plasma membranes of macrophages is associated with increased inflammatory signaling. Cholesterol efflux via the transporters ABCA1, ABCG1, and SR‐BI to high‐density lipoprotein (HDL) particles is a critical mechanism to maintain cellular cholesterol homeostasis. Little is known about the impact of the obese microenvironment on cholesterol efflux capacity (CEC) of macrophages. In this study, the CEC of obese‐derived primary adipose‐tissue macrophages (ATM) is evaluated and the in vivo microenvironment is modeled in vitro to determine mechanisms underlying modulated CEC.Materials and Methods: F4/80+ ATM are labeled with 3H‐cholesterol ex vivo, and CEC and ABCA1/ABCG1 protein levels are determined. Total, ABCA1‐dependent, and ABCA1‐independent CECs are determined in J774 macrophages polarized to M1 (LPS&IFNγ), M2 (IL‐4&IL‐13), or metabolic phenotypes (glucose, insulin, and palmitic acid).Results: Obese ATM exhibit enhanced CEC and ABCA1 and ABCG1 expression compared to lean ATM. In contrast, ABCA1‐CEC is suppressed from M1 polarized macrophages compared to untreated in vitro, by activation of the JAK/STAT pathway. Incubation of macrophages in vitro in high glucose augments cAMP‐induced ABCA1 protein expression and ABCA1‐CEC.Conclusions: These novel findings demonstrate remarkable plasticity of macrophages to respond to their environment with specific modulation of ABCA1 depending on whether classical pro‐inflammatory or metabolic cues predominate.

13 October 2016 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
PDF file
HKH. Khalil
H. Khalil
Celine MurrinCeline Murrin
Celine Murrin
MOM. O'Reilly
M. O'Reilly
KVK. Viljoen
K. Viljoen
RSR. Segurado
R. Segurado
CKC.C. Kelleher
C.C. Kelleher

1 August 2014 in Atherosclerosis
Verified
Journal Article
Closed access
MOM. O'REilly
M. O'REilly
OFO. Finucane
O. Finucane
DJD. Jones
D. Jones
AMAndrew Murphy
Andrew Murphy
CLClaire Lyons
Claire Lyons
FMFiona McGillicuddy McGillicuddy
Fiona McGillicuddy McGillicuddy